Refer Me

Get ReferralsAI ApplyTailor ResumeFor YouPremium
Sign in
Janux Therapeutics

Janux Therapeutics

La Jolla, California, United States

51-200 Employees

Healthcare Tech

Project Team Lead

San Diego, CA, US

Posted on Apr 1, 2026

Full TimeSeniorOn SiteStrategic Management

Job Description

Janux Therapeutics is seeking a Project Team Leader (PTL) to provide visionary leadership and strategic direction for the development and execution of Integrated Asset Plans across our oncology and autoimmune portfolio. The PTL will serve as the single point of accountability for the seamless delivery of project milestones and outcomes for one or more assets, guiding them from First-in-Human/First-in-Patient (FIH/FIP) studies through Phase 1–3 clinical development and comprehensive life-cycle management.

This role requires a leader with exceptional expertise in oncology drug development, a proven ability to drive cross-functional teams, optimizing team alignment, governance, and overall team health. The PTL will be entrusted with critical oversight of asset budgets, investment recommendations, and continuous optimization of asset strategies, ensuring alignment with Janux’s broader portfolio objectives.

About Janux Therapeutics

Janux Therapeutics is a biopharmaceutical company focused on developing novel immunotherapies to treat cancer and other diseases. Leveraging cutting-edge technologies and innovative research, Janux Therapeutics aims to revolutionize the field of immunotherapy and provide new treatment options for patients worldwide.

Job overview

Employment type

Full Time

Experience level

Senior

Work type

On Site

Department

Strategic Management

Posted

on Apr 1, 2026

About

Job Link

jobs.lever.co

Financials

Type

public

Annual Revenue

--

Market Cap

$1.9B+

Subscribe to Refer Me premium to get referred to this role at Janux Therapeutics!

Your career is worth investing in.

Get unlimited referrals with Premium.

Upgrade to Premium

Refer Me logo

Refer Me

Referrals

Get Referred

Subscription

© 2026 Crucible Fund LLC. All rights reserved.